Abeomics

ABEOMICS, a San Diego, California based biotech company was founded in 2013 by Dr. Gita Singh to provide CRO service to biotech, pharma companies and the scientists in the research institutes and universities. Subsequently, Abeomics had started developing and commercialising reagents for the scientific study of human biology and diseases and to produce new diagnostic assays and potential therapies for such diseases such as cancer, apoptosis (programmed cell death), molecular signaling pathways, cellular aging, metabolic disorder, neuro-degenerative, genetic and infectious diseases.